InsiderTrades

Form 4 for ATRC AtriCure, Inc.

Accepted 2024-03-05 00:00:00 ET · period of report 2024-03-01 · accession 0001323885-24-000036 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-03-05 2024-03-01 ATRC Wirick Angela L CFO A - Grant $0.00 +47.5K 134.1K +55% $0
D 2024-03-05 2024-03-01 ATRC Wirick Angela L CFO M - OptEx $16.95 +5,000 139.1K +4% +$84.8K
D 2024-03-05 2024-03-01 ATRC Wirick Angela L CFO M - OptEx $16.95 -5,000 0 -100% -$84.8K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-03-01 A A 31,008 $0.00 117,609 D — — (F1) The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant.
2 Common Common Stock 2024-03-01 M A 5,000 $16.95 139,070 D — —
3 Common Common Stock 2024-03-01 A A 16,461 $0.00 134,070 D — — (F2) The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The award had Company performance goals and a service period requirement which were met.
4 Derivative Non-qualified Stock Option (right to buy) 2024-03-01 M D 5,000 $16.95 0 D $16.95 · 2015-07-28 to 2024-07-28 5,000 Non-qualified Stock Option (right to buy) (F3) These options were granted on July 28, 2014. These options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years.